bioXXmed AG (FRA:T5O)
Germany · Delayed Price · Currency is EUR 1.020
+0.020 (2.00%)
Last updated: Oct 6, 2026, 7:36 PM CET
bioXXmed AG Revenue
bioXXmed AG had revenue of -269.00 EUR in the twelve months ending June 30, 2026. In the year 2025, bioXXmed AG had annual revenue of 16.73K with 378.99% growth. That makes bioXXmed AG the 47,846th largest company in the world by revenue and 662nd in Germany.
Revenue (ttm)
-269.00
Revenue Growth
+378.99%
P/S Ratio
-1,030.86
Revenue / Employee
-134.50
Employees
2
Market Cap
277.30K
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 16.73K | 13.24K | 378.99% |
| Dec 31, 2024 | 3.49K | -13.91K | -79.93% |
| Dec 31, 2023 | 17.40K | 5.17K | 42.27% |
| Dec 31, 2022 | 12.23K | -32.39K | -72.59% |
| Dec 31, 2021 | 44.63K | 8.63K | 23.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Biotest GmbH & Co. KGaA | 648.90M |
| Novogenia AG | 52.35M |
| Paion AG | 14.81M |
| MagForce AG | 1.08M |
| co.don AG | 22.00K |
| Biomark Diagnostics | 17.14K |
| 2invest AG | -1.64M |